<<

South Asian of American College of Clinical Pharmacology 8th Annual Conference on

Translational Clinical Pharmacology in Drug Development

23rd - 25th April 2015 (Thursday to Saturday), Mumbai (India) Venue: Nehru Centre, Dr Annie Besant Rd, Worli, Mumbai, MH 400018

Organized in collaboration with

National Institute for Research in Reproductive Health, ICMR, Parel, Mumbai Department of Pharmacology & Clinical Pharmacology, Seth G S Medical College and KEM Hospital, Mumbai Maharashtra University of Health , Nashik

PRECONFERENCE WORKSHOP- I: 23rd April 2015 Topic: “Application of Translational Pharmacokinetics (PK)/Pharmacodynamics (PD) Principles in the Development of Anti-infective drugs”

PRECONFERENCE WORKSHOP- II: 23 rd April 2015 Topic: “Medical and

CONFERENCE: 24 and 25 April 2015 TOPICS FOR SCIENTIFIC SESSIONS Role of Clinical Pharmacology Discipline in Drug Challenges in translating efficacy between animal Discovery and Development models and humans Are we getting the dose right in late stage clinical Translational research in Oncology- safety trial? – Lost in Translation? Translational research in diabetes- drug safety Translational research in need based Asia Translational research in Infectious diseases- vector Translational research in Infectious diseases- born diseases Tuberculosis Regulatory issues in international studies SUBMISSION OF ABSTRACTS: All abstracts can be submitted via e-mail only to [email protected] Abstracts should not exceed 250 words. Please indicate whether you intend to present the paper at oral/poster session. The should be structured and contain title, authors, address of institution, aims, objectives, brief methodology, results and conclusion (Annexure 1). The final decision to accept the abstract for ORAL OR POSTER session will be made by the Scientific Committee. This decision will be final and binding . The last date for submission of abstract is 15 th March 2015. REGISTRATION: Pre-conference Pre-conference Two day conference (24-25th April 2015) WORKSHOP-1 WORKSHOP-2 Before 1st March From 1st March 2015 ( 23rd April 2015)* (23rd April 2015)* 2015 (Spot registration) Indian Delegates Students # Rs. 2000/- Rs. 2000/- Rs. 3000/- Rs. 3500/- Academics/Faculty Rs. 3000/- Rs. 3000/- Rs. 4000/- Rs. 5000/- Industry RS. 4000/- RS. 4000/- Rs. 6000/- Rs. 8000/- International Students # Rs.2000/- Rs.2000/- Rs.4000/- Academics/Faculty Rs.3000/- Rs.3000/- Rs.6000/- Industry Rs.5000/- Rs.5000/- Rs.10000/- *Seats for workshop are limited to 60 and will be given on first come basis. Please enquire about the availability of seats before registering to workshop by sending email to [email protected] # Letter of permission from Head of Department should be attached Payment for Registration can be done as follows: A. Demand draft/cheque payable at par at Mumbai. The cheque/draft should be in favour of “South Asian Chapter of ACCP” and send to: SAC-ACCP 2015 Conference Secretariat , 1st floor, NIRRH, ICMR, Govt. of India, Parel, Mumbai- 400 012 India. B. Electronic Fund Transfer. The relevant details are: 1. For credit to Savings Bank A/c No. 0110101103475, Canara Bank Branch: Parel Mumbai; IFSC Code: CNRB0000110 (5th character is zero) MICR Code: 400015055, Branch Code: 000110. 2. Name of Remitter:______(Please mention the name of the individual or sponsoring organization) 3. Purpose of Remittance: 8th Annual Conference of SAC-ACCP In addition send online registration form to: [email protected]

Organizing Committees ∑ President Dr. Nilima Kshirsagar ∑ Vice-President Dr. Nithya Gogtay, Dr. Sanish Davis ∑ Organizing Secretary Mr. Sagar S. Bachhav Mr. Swapnil Dhawane Ms. Sarayu Pai Dr. Pankaj Sarkate Scientific Committee Chairman:- Dr. Ashok Vaidya Co- Chair - Dr. Gangadhar Sunkara Dr. Manoj Jadhav, Dr. Sanish Davis, Dr. Anish Desai, Dr. Kiran Marthak Dr. Parthasarathi Gurumurthy, Dr. Deven Parmar, Dr. Lalitha Savardekar, Dr. Taruna Gupta, Dr. Nirmala Rege., Dr. Nithya Gogtay ∑ Treasurer and Finance Dr. Nirmala Rege, Mr. Vishal Shinde

Faculty for Workshops

Pre-conference Workshop (23rd April 2015)* Prof Tawanda Gumbo, Baylor Institute of Immunology Research , Dallas, TX, USA Dr. Ayyappa Chaturvedula, GVK-Bio, India Dr. Gangadhar Sunkara, Novartis Ltd., NJ, USA Dr Subramanian Ganesan, Novartis, India

Conference (24-25th April 2015) Dr. Gang adhar Sunkara, Novartis Ltd., NJ, USA. Prof. Mark A. Atkinson, University of Florida, FL, USA Dr. Robin Ferner, Univ. of Birmingham, UK Prof. Bernd Meibohm, ACCP President, Univ. of Tenn, USA Dr Praveen Myneni, NATCO, India Prof. Mike Conlon, University of Florida, FL, USA. Dr. Dakshina Chilkuri, MA, USA Prof Tawanda Gumbo, UT Southwestern Med Center, TX, USA Dr. Steve Kern, GATES Foundation, USA Dr Barbara Werner, Novartis Ltd, NJ,USA Dr Peter K Hoffmann, Novartis, USA Dr. Saumya Saminathan, NIRT, Chennai Dr. Nilima A. Kshirsagar, ICMR, Mumbai Dr. D. Behra, India (TBC) Dr. Neena Valecha, NIMR, New Delhi Dr Subramanian Ganesan, Novartis, India Dr Jay Prakash Jain, Novartis, Hyderabad Dr Stephan Chalon, MMV, Switzerland

Annexure 1

Font for whole abstract Times new roman Title Font size- 12 and Bold Author Name Font size - 12 Surname Initials, Surname Initial,…. (underline presenting author’s name) Institution Name Font Size: 10, Institute name, city, state, country BACKGROUND Font size 10 METHODS Headings like background, methods… in CAPITAL letters and bold RESULTS CONCLUSONs NOTE: - Mention ORAL or POSTER on Top. However, the selection of abstract for ORAL/POSTER session will be made by chairman of scientific committee. This decision will be final and binding . - Provide detailed address and contact details in email

Template

POSTER SESSION

Outcomes research resources in India: current status, need and way forward.

Shah J, Pawaskar A, Kumar S, Kshirsagar NA.

Maharashtra University of Health Sciences, Nashik, Maharashtra India.

BACKGROUND: Despite their importance, the number of outcomes research studies conducted in India are lesser than other countries. Information about the distribution of existing outcomes research resources and relevant expertise can benefit researchers and research groups interested in conducting outcomes research studies and policy makers interested in funding outcomes research studies in India. We have reviewed the literature to identify and map resources described in outcomes research studies conducted in India. METHODS: We reviewed the following online biomedical databases: Pubmed, , CINAHL, and and selected articles that met the following criteria: published in English, conducted on Indian population, providing information about outcomes research resources (databases/registries/electronic medical records/electronic healthcare records/hospital information systems) in India and articles describing outcomes research studies or epidemiological studies based on outcomes research resources RESULTS: Of the 126 articles retrieved, 119 articles were selected for inclusion in the study. The tally increased to 133 articles after a secondary search. Based on the information available in the articles, we identified a total of 91 unique research resources. We observed that most of the resources were Registries (62/91) and Databases ( 23/91) and were primarily located in Maharashtra (19/91) followed by Tamil Nadu (11/91), Chandigarh (8/91) and Kerala (7/91) States. These resources primarily collected data on Cancer (44/91), Stroke (5/91) and Diabetes (4/91). Most of these resources were Institutional (38/91) and Regional resources (35/91) located in Government owned and managed Academic Institutes/Hospitals (57/91) or Privately owned and managed non - Academic Institutes/Hospitals (14/91). Data from the Population based Cancer Registry, Mumbai was used in 41 peer reviewed publications followed by Population based Cancer Registry, Chennai (17) and Rural Cancer Registry Barshi (14). CONCLUSIONS: Given the importance of Outcomes research, relevant resources should be supported and encouraged which would help in the generation of important healthcare data that can guide health and research policy. Clarity about the distribution of outcomes research resources can facilitate future resource and funding allocation decisions for policy makers as well as help them measure research performance over time.